je.st
news
Synta Announces Positive One-Year Follow-up Results for the GALAXY-1...
2013-10-27 03:04:00| Biotech - Topix.net
Synta Pharmaceuticals Corp. today announced presentation of results from the GALAXY-1 trial, a global, randomized, multi-center study designed to identify the patients with advanced non-small cell lung adenocarcinoma most likely to benefit from second-line treatment with the Company's lead drug candidate, the Hsp90 inhibitor ganetespib, in ... (more)
Tags: results
positive
announces
followup
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||